DCM
BIO icon

Dupont Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Dupont Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-159
Closed -$66.9K – 803
2022
Q4 		$66.9K Sell
159
-114
-42% -$46K ﹤0.01% 1024
2022
Q3 		$114K Buy
273
+123
+82% +$61.3K 0.01% 991
2022
Q2 		$74K Sell
150
-497
-77% -$259K ﹤0.01% 1231
2022
Q1 		$364K Buy
647
+58
+10% +$35K 0.01% 875
2021
Q4 		$445K Sell
589
-1,227
-68% -$918K 0.02% 854
2021
Q3 		$1.35M Sell
1,816
-532
-23% -$399K 0.04% 446
2021
Q2 		$1.51M Sell
2,348
-2,383
-50% -$1.45M 0.04% 436
2021
Q1 		$2.7M Buy
4,731
+1,799
+61% +$1.07M 0.07% 258
2020
Q4 		$1.71M Sell
2,932
-978
-25% -$557K 0.04% 379
2020
Q3 		$2.02M Sell
3,910
-880
-18% -$446K 0.04% 307
2020
Q2 		$2.16M Sell
4,790
-360
-7% -$159K 0.05% 298
2020
Q1 		$1.8M Sell
5,150
-964
-16% -$354K 0.04% 314
2019
Q4 		$2.26M Buy
6,114
+1,909
+45% +$673K 0.05% 325
2019
Q3 		$1.4M Buy
4,205
+1,246
+42% +$406K 0.03% 429
2019
Q2 		$925K Buy
2,959
+1,100
+59% +$329K 0.02% 570
2019
Q1 		$568K Sell
1,859
-200
-10% -$54K 0.01% 715
2018
Q4 		$478K Buy
+2,059
New +$552K 0.01% 749

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dupont Capital Management's BIO Position: Q1 2023 in Review

Dupont Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 159 shares — an estimated $66.9K sold.

Dupont Capital Management first reported a position in BIO in Q4 2018 and held it in 17 quarters. The position peaked at $2.7M in Q1 2021. 505 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

  • Dupont Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 159 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $66.9K.
  • Dupont Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 17 quarters.
  • Dupont Capital Management's Bio-Rad Laboratories Class A position peaked at $2.7M in Q1 2021.
  • 505 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.